Newsroom

HIPS Logo
News
Biomedical Research strengthened in Saarland through the new Leibniz Campus
The Leibniz Institute for New Materials (INM), Saarland University (UdS) and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) are launching the Leibniz Science Campus “Living Therapeutic Materials” on 1 July 2020. In a competitive process, the Leibniz Association approved a grant of 900,000 € for joint research into new materials for the personalised administration of biotherapeutics, based at the Saarland campus. In addition to the funding from the Leibniz Association, the INM, the HIPS and the UdS are also contributing around three million euros to the project from their own funds. Furthermore, the State Chancellery is also contributing an additional 400,000 €.
29.06.2020
HIPS
Prof. Anna Hirsch
News
EU funds training network for young researchers
Prof Anna K. H. Hirsch recently received a prestigious European grant with a total funding volume of 3.2 million euros to initiate an Innovative Training Network (ITN) in the framework of the Marie Skłodowska-Curie actions. Hirsch leads the department Drug Design and Optimization at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) in Saarbrücken, a site of the Helmholtz Centre for Infection Research (HZI) on the campus of the Saarland University.
25.06.2020
HIPS
Blutproben
News
Start of HZI’s nationwide antibody study
Scientific data indicate that many COVID-19 cases are not recorded due to mild or asymptomatic infections. For this reason, there is at the time no sufficient data on how many people in Germany have already been infected and thus have established a presumed immunity against SARS-CoV-2. However, these data play an important role in assessing and forecasting the further course of the pandemic.
17.06.2020
HZI Campus
Mikroskopische Aufnahme einer Lungengewebsprobe mit einer aktiven Zytomegalie-Infektion. Charakteristisch sind vergrößerte Lungenzellen mit Einschluss im Zellkern.
News
Protection against the immune system
Virologists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig have identified a crucial survival factor in viruses. Their results were recently published in the scientific journal Proceedings of the National Academy of Sciences and could lead to a paradigm shift in virus immunology.
10.06.2020
HZI Campus
Health Care System
News
CORESMA provides evidence-based data on measures against coronavirus
09.06.2020
HZI Campus
Meningokokken (orange) haben sich an menschliche Wirtszellen (grün) angeheftet. Rasterelektronenmikroskopische Aufnahme in Falschfarbendarstellung.
News
Small Protein, Big Impact
In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria. Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding protein ProQ is involved in the activation of more than 250 bacterial genes. ProQ ensures that meningococci can better repair their DNA if damaged and it makes them resistant to oxidative stress. Both these factors contribute significantly to the bacteria's pathogenic properties. This was reported by research groups led by the Würzburg scientists Christoph Schoen from the Julius-Maximilians-Universität (JMU) and Jörg Vogel from the Helmholtz Institute for RNA-based Infection Research (HIRI) in the journal Nature Communications. The HIRI is a joint institution of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the JMU.
04.06.2020
HIRI

HZI in the media

Seuchen aus dem KI-Labor: Kann Künstliche Intelligenz bereits Biowaffen bauen?

... beeindruckendes Ergebnis“, sagt Jakob Wirbel vom Helmholtz-Zentrum für Infektionsforschung (HZI). „Trotzdem schlafe ich momentan noch ...

15.10.2026
|
Der Tagesspiegel
Impfung sinnvoll? Erst Erkältungen, dann Corona und Grippe – So schützen Sie sich

... Lange, Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und Mitglied der Ständigen ...

14.10.2026
|
DIE WELT
HMN 2026: How crawling motility may be far older than previously thought

also included Japanese microbiologists and collaborators from IST Austria and HZI Braunschweig (Germany), demonstrated that actin inhibitors

14.10.2026
|
Health Medicine Network
Neue Empfehlungen der WHO zur COVID-19-Impfung

... in der Abteilung „Virale Immunologie“ am Helmholtz-Zentrum für Infektionsforschung (HZI), hat die WHO als externer ...

13.10.2026
|
DeutschesGesundheitsPortal
Metax brings genome-wide coverage into focus for sharper microbial profiling

tool called Metax, developed by researchers at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and described in the

12.10.2026
|
Bioengineer.org
New Hope for Fighting C. difficile Infections

parts of the microbiome. HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University. “We

12.10.2026
|
Technology Networks
HZI erhält 724.000 Euro: Makrophagen sollen Lungenfibrose bekämpfen

... auch gezielte Forschungsmittel an das Helmholtz-Zentrum für Infektionsforschung (HZI): Die Forschungsgruppe von Prof ...

12.10.2026
|
Ad Hoc News
Fieser Magen-Darm-Erreger breitet sich immer stärker aus: Infektionen in England steigen drastisch

... nur in England vor. Laut Angaben des Helmholtz Zentrum für Infektionsforschung ist es dem Erreger ...

12.10.2026
|
Frankfurter Rundschau online
EU fördert Entwicklung von Immunzelltherapie bei Lungenfibrose

... und Belgien. Aus Deutschland sind das Helmholtz-Zentrum für Infektionsforschung (HZI), das Fraunhofer-Institut für Toxikologie und ...

12.10.2026
|
MTA Dialog
Forscher entwickeln Wirkstoff gegen Pockenviren

... weitere Versuche herstellen.

 

Auch das Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig ist beteiligt. Die ...

11.10.2026
|
t-online.de
Warum Ballaststoffe nicht bei jedem gleich wirken

... unterschiedlichen Regionen unterscheidet. Der Forscher vom Helmholtz-Zentrum für Infektionsforschung konnte in seiner Studie zeigen, ...

10.10.2026
|
rbb radioeins
Gut bacteria team up with diet to decide who rules the microbiome

Tawk, Youssef El Mouali and colleagues at the Helmholtz Centre for Infection Research, together with collaborators at the University of

09.10.2026
|
Bioengineer.org

Register now for the HZI newsletter